SENIOR JOURNAL.COM - Senior Citizens Information and News

Front Page    Search     Contact Us     Advertise in Senior Journal


SeniorJournal.com

INDEX


FRONT PAGE

PAGE TWO
More Headlines

 • General Features

 • Find Help

 • SENIOR ALERTS

 • Baby Boomers

 • Odds & Ends

Health-Fitness

 • Aging

 • Alzheimer's & Dementia

 • Fitness

 • Health/Medicine

 • Medical Research

 • Nutrition/Vitamin

Government

 • Politics

 • Medicare

 • Medicare Drug Program

 • Medicare Q&A - Dear Marci

 • Medicaid

 • Social Security

 • Social Security, Medicare Q&A

 • Social Security Reform

Enjoying Life

 • Books

 • Entertainment

 • Features

 • Grandparents

 • Senior Statistics

 • Senior Stars

 • Sex & Seniors

 • Sports

 • Travel

 • Senior Volunteers

On The Web

 • Links - Senior

 • Senior Friendly Business Links

 • Sites We Like

Elderly Issues

 • Elder Care

 • Assistance for Elderly

 • Housing

Money 

 • Discounts

 • Guarding Your Wealth for Seniors

 • Money Matters

 • Reverse Mortgage

 • Retirement

Thinking

 • Opinions



Senior Journal: Today's News and Information for Senior Citizens & Baby Boomers

More Senior Citizen News and Information Than Any Other Source - SeniorJournal.com

• Go to Alzheimer's, Dementia & Mental Health or More Senior News on the Front Page

 

Click here to vitamins without a pill.


 
 

E-mail this page to a friend!

Alzheimer's, Dementia & Mental Health

Dementia in Older Men Associated with High Levels of Female Hormone

High estrogen may be consequence of, or early AD sign, rather than cause

July 24, 2006 - A new study has found that higher estrogen levels in older men are associated with an increased risk of dementia. By contrast, levels of testosterone were not associated with cognitive decline. An earlier study found that older women receiving estrogen therapy had increased risk of dementia.

 

Related Stories

 
 

IVIg Headlines Alzheimer's Treatments at International Conference

Therapies show promise, address multiple aspects of the disease

July 19, 2006 – In April of last year, SeniorJournal.com published a story, " IVIg Therapy May Improve Cognitive Function in Alzheimer's Patients," that became one of the most read stories the Website had ever published (see story in sidebar). Yesterday, IVIg was a hot topic again at a conference in Madrid sponsored by the Alzheimer's Association. It was, however, among several drugs showing promise in the battle against Alzheimer's that were discussed at the conference. Read more...

Diabetes Drug Shows Promise in Treating Alzheimer’s

In small study treatment appeared to reduce Alzheimer’s progression

July 17, 2006 – It’s a small study but the results are intriguing – the possibility that a drug approved by the Food and Drug Administration to treat type 2 diabetes may also help people with Alzheimer’s disease to better hold on to memory and brain function over a longer period of time. Read more...

Senior Citizens Play Computer Game to Determine Memory Loss

Scientists say FreeCell can be adapted to spot early signs of dementia

July 18, 2006 – Scientists said today they are using a popular computer card game – FreeCell – to help distinguish between senior citizens with memory problems and those without cognitive problems. Read more...

Weight Loss Precedes Dementia in Women

Loss of weight can begin up to 10 years before memory loss

July 16, 2006 - Mayo Clinic researchers have found that women who develop dementia experience a decline in weight as many as 10 years prior to the onset of memory loss, compared to peers who do not develop dementia. Read more...


Read more on Alzheimer's, Dementia & Mental Health

 

As our population ages, the impact of dementia will grow. By the year 2050, some 13 million Americans could have Alzheimer's disease, which is the most common cause of dementia. Researchers are searching to understand risk factors and some studies have suggested that sex hormones play a role.

One large study showed that women receiving estrogen therapy had an increased risk of cognitive impairment and dementia. However, the evidence for how testosterone levels affect men is contradictory.

To better understand the role of sex hormones in dementia, the researchers studied whether older men's levels of testosterone and estrogen were associated with their risk of cognitive decline and developing dementia, including Alzheimer's disease.

The researchers, led by Mirjam Geerlings, Ph.D. of the University Medical Center Utrecht, examined data from the prospectively studied population-based cohort of 2974 Japanese-American men aged 70 to 91 who participated in the Honolulu-Asia Aging Study.

Participants showed no signs of dementia at baseline in 1991-1993, at which time fasting blood samples were drawn. The researchers measured the levels of testosterone and estradiol, the major estrogen in humans, in the samples and the men were reexamined for evidence of cognitive decline or dementia in 1994-1996 and 1997-1999 using the Cognitive Abilities Screening Instrument (CASI). At each exam, researchers also collected physical, demographic and medical information.

A total of 2,300 men completed the study and 223 were diagnosed with incident dementia during the follow-up period. 134 men developed Alzheimer's disease, and 44 developed vascular dementia. The researchers used Cox regression analyses, adjusting for age and other covariates, to see if hormone levels were associated with risk of developing dementia

"Levels of bioavailable testosterone were not associated with risk of cognitive decline and incident dementia," they report. "In contrast, higher levels of bioavailable estradiol were associated with an increased risk for cognitive decline and Alzheimer's disease."

Note: "bioavailable" refers to the degree to which a substance can be absorbed and utilized by those parts of the body on which it is intended to have an effect.

For each standard deviation increase in estradiol level, the risk for the disease went up by 25 percent. Furthermore, compared with the lowest tertile of estradiol, men in the middle and highest tertile had .24 and .28 points lower CASI scores, respectively, for each year increase in age.

Note: "Estradiol" is an estrogenic hormone produced in the ovaries and synthesized for use in treating estrogen deficiency and breast cancer.

The researchers hypothesize that the estradiol association could be explained by increased aromatase activity in the brain, which may be associated with a neurodegenerative process. It is then possible that the high levels of estradiol are a consequence or early marker of Alzheimer's disease rather than a cause.

Some caution is needed when interpreting the results, as, due to death or refusal, some men could not be given a diagnosis of dementia or follow-up cognitive testing.

In conclusion, the authors report, "our findings of an increased risk of cognitive decline and Alzheimer's disease associated with higher estradiol are similar to recent findings in postmenopausal women. Further studies are needed to examine whether there are mechanisms by which estradiol may increase risk of cognitive decline and dementia."

Notes:

The study is in the August issue of Annals of Neurology, a journal published by John Wiley & Sons. (http://www.interscience.wiley.com/journal/ana).

Article: "Endogenous sex hormones, cognitive decline and future dementia in old men." Geerlings, Mirjam; Strozyk, Dorothea; Masaki, Kamal; Remaley, Alan; Petrovitch, Helen; Ross, Webster; White, Lon; Launer, Lenore. Annals of Neurology; August 2006; (DOI: 10.1002/ana.20918).

 

Search for more about this topic on SeniorJournal.com

Google Web SeniorJournal.com

Click to More Senior News on the Front Page

Copyright: SeniorJournal.com

     Back to Top

 

Published by New Tech Media - www.NewTechMedia.com

Other New Tech Media sites include CaroleSutherland.com, BethJanicek.com, www.DeweySquare.com, SASeniors.com, DrugDanger.com, etc.

E-mail - editor@SeniorJournal.com